multiple dose studies [Design Issues]
Hello Loky do!
![[image]](img/uploaded/image254.jpg)
Considering as a sponsor, the analysis of solifenacin adds a cost. But as a regulator- if you are taking the sample- why it is not analyzed? Any SE relation with PK would not be feasible, then.
Regards,
Divyen
❝ I'm a little confused why to analyze solifenacin as it is immediate release and the concern towards tamsulosin as it is the delayed release one, even if I took into consideration the washout of both, are the results of solifenacin, in this case, affect those of tamsulosin?
❝
![[image]](img/uploaded/image254.jpg)
Considering as a sponsor, the analysis of solifenacin adds a cost. But as a regulator- if you are taking the sample- why it is not analyzed? Any SE relation with PK would not be feasible, then.
Regards,
Divyen
Complete thread:
- multiple dose studies Loky do 2024-03-04 10:27 [Design Issues]
- multiple dose studies dshah 2024-03-08 17:36
- multiple dose studies Loky do 2024-03-11 11:20
- multiple dose studiesdshah 2024-03-12 17:37
- multiple dose studies Loky do 2024-03-11 11:20
- multiple dose studies dshah 2024-03-08 17:36